This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Jerzy Szkudlarek: Innovator in Cancer Research
Introduction
Jerzy Szkudlarek is a prominent inventor based in Wroclaw, Poland. He has made significant contributions to the field of cancer research, particularly in the development of monoclonal antibodies. His work focuses on targeting specific antigens associated with human renal cancer, which has implications for diagnosis and treatment.
Latest Patents
Szkudlarek holds a patent for "Monoclonal antibodies to cell surface antigens of human renal cancer." This patent describes the preparation and use of monoclonal antibodies that bind to glycoproteins of 160Kd, 120Kd, and 115Kd, as well as a glycolipid, a HLA heavy chain, and group A and B blood antigens. This innovation represents a significant advancement in the fight against renal cancer.
Career Highlights
Jerzy Szkudlarek is affiliated with the Sloan-Kettering Institute for Cancer Research, where he conducts his research. His work has been instrumental in advancing the understanding of cancer biology and developing targeted therapies.
Collaborations
Some of his notable coworkers include Lloyd J. Old and Kenneth O. Lloyd. Their collaborative efforts have contributed to the success of various research projects and innovations in cancer treatment.
Conclusion
Jerzy Szkudlarek's contributions to cancer research through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to inspire advancements in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile